Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$93.41 -1.80 (-1.90%)
At close: Oct 1, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Return on Assets [ROA] (2017 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) posted Return on Assets [ROA] of -46.69% for Q2 2026, up 1.52 percentage points from -48.22% a year earlier but down 2.75 percentage points from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Return on Assets [ROA] (2017 - 2026) Analysis & Trends

For FY2025, Rhythm Pharmaceuticals' Return on Assets [ROA] came in at -45.05%, up 26.83 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a five-year change of +9.02 percentage points (FY2020 to FY2025).
  • In prior years, Rhythm Pharmaceuticals' Return on Assets [ROA] was -71.89% in FY2024 (-20.25 pp), -51.64% in FY2023 (-0.77 pp), -50.88% in FY2022 (-23.93 pp) and -26.95% in FY2021 (+27.12 pp).
  • Quarterly Return on Assets [ROA] has run from a low of -92.62% in Q1 2024 to a high of -14.42% in Q3 2021 over five years.
  • On a year-over-year basis, Return on Assets [ROA] increased in five of the last eight quarters, with an average year-over-year change of +13.64 percentage points.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2025, with a gain of 49.30 percentage points; the weakest was Q2 2022, with a drop of 57.82 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -43.94% (Q1 2026), -39.83% (Q4 2025) and -43.73% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Rhythm Pharmaceuticals 6.55 Bn 5.42 Bn 62.32 Mn -46.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -46.69%
Mar 31, 2026 -43.94%
Dec 31, 2025 -39.83%
Sep 30, 2025 -43.73%
Jun 30, 2025 -48.22%
Mar 31, 2025 -43.32%
Dec 31, 2024 -68.95%
Sep 30, 2024 -69.47%
Jun 30, 2024 -81.02%
Mar 31, 2024 -92.62%
Dec 31, 2023 -53.77%
Sep 30, 2023 -55.87%
Jun 30, 2023 -55.59%
Mar 31, 2023 -49.59%
Dec 31, 2022 -46.92%
Sep 30, 2022 -56.79%
Jun 30, 2022 -68.52%
Mar 31, 2022 -61.25%
Dec 31, 2021 -20.31%
Sep 30, 2021 -14.42%
API Access

Rhythm Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RYTM&period=max&api_key=YOUR_API_KEY